| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000010916 |
| Receipt No. | R000012775 |
| Official scientific title of the study | Industrial Nitric oxide and Nitrogen gas inhalation for patients with congenital heart disease during the perioperative management |
| Date of disclosure of the study information | 2013/06/10 |
| Last modified on | 2016/06/10 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Industrial Nitric oxide and Nitrogen gas inhalation for patients with congenital heart disease during the perioperative management | |
| Title of the study (Brief title) | Industrial Nitric oxide and Nitrogen gas inhalation for patients with congenital heart disease during the perioperative management | |
| Region |
|
|
| Condition | ||||||
| Condition | All Congenital Heart Desease | |||||
| Classification by specialty |
|
|||||
| Classification by malignancy | Others | |||||
| Genomic information | NO | |||||
| Objectives | |
| Narrative objectives1 | The aim of this study is to evaluate the safety and efficasy of the industrial Nitric oxide and Nitrogen gas inhalation. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Patient hemodynamics in perioperative period |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Inhalation of the industrial Nitric oxide and Nitrogen gas | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with Pulmonary hypertension by echocardiography | |||
| Key exclusion criteria | Patients without Pulmonary hypertension by echocardiography or those who has no congenital heart defect | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshifumi Fujimoto |
| Organization | Shimane University |
| Division name | Cardiovascular Surgery |
| Address | 89-1, Ennya, Izumo City, Shimane |
| TEL | |
| Public contact | |
| Name of contact person | |
| Organization | Shimane University |
| Division name | Cardiovascular Surgery |
| Address | |
| TEL | |
| Homepage URL | |
| yoshi-sleepingcat@crest.ocn.ne.jp | |
| Sponsor | |
| Institute | Department of Cardiovascular
And Chest Surgery, Shimane University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012775 |